Related Experiment Videos

Localization of an epithelial-specific receptor kinase (EDDR1) to chromosome 6q16

A N Shelling1, R Butler, T Jones

  • 1ICRF Laboratories, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

Genomics
|January 20, 1995
PubMed

Insights

Researchers identified a novel receptor tyrosine kinase, EDDR1, in ovarian cancer cells. The EDDR1 gene was localized to chromosome 6q16, providing insights into its potential role in epithelial cancers.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Ovarian cancer is a significant health concern, necessitating the identification of novel therapeutic targets.
  • Receptor tyrosine kinases (RTKs) play crucial roles in cell signaling and are frequently implicated in cancer development.

Purpose of the Study:

  • To isolate and characterize a novel receptor tyrosine kinase (EDDR1) from an epithelial ovarian cancer cell line.
  • To determine the chromosomal localization of the EDDR1 gene.

Main Methods:

  • Complementary DNA library screening of SKOV-3 cells.
  • Amino acid sequence analysis to predict protein structure and homology.
  • Polymerase Chain Reaction (PCR) amplification using somatic cell hybrids.
  • Fluorescence in situ hybridization (FISH) for precise gene mapping.

Main Results:

  • A novel receptor tyrosine kinase, EDDR1, was isolated and characterized.
  • EDDR1 possesses a unique N-terminal domain with homology to Factor VIII and a C-terminal catalytic domain characteristic of type II RTKs, showing homology to TRK-2H.
  • The EDDR1 gene was mapped to chromosome 6q16.

Conclusions:

  • EDDR1 is a novel type II receptor tyrosine kinase expressed in epithelial cells.
  • The specific chromosomal localization of EDDR1 to 6q16 provides a basis for further investigation into its function and potential role in ovarian cancer and other epithelial malignancies.

Related Concept Videos